24656560

Moolenaar LM

2014

Cost-effectiveness of treatment strategies in women with PCOS who do not conceive after six cycles of clomiphene citrate.

24656700

Chung JP

2014

A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.

24656701

Huang Y

2014

Cognitive disorder in women with polycystic ovary syndrome: a remote complication.

24657792

Bailey AP

2014

Effect of body mass index on in?vitro fertilization outcomes in women with polycystic ovary syndrome.

24658986

Davari-Tanha F

2014

Bipolar disorder in women with polycystic ovarian syndrome (PCO).

24659742

Jo? JG

2014

[Epigenetic background of the most common non-oncologic gynecological diseases].

24661732

Leonhardt H

2014

Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antim?llerian hormone, free testosterone, and glucose disposal rate.

24664271

Guler I

2014

Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance.

24666752

Ladr?n de Guevara A

2014

Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations.

24668721

Haqq L

2015

The Effect of Lifestyle Intervention on Body Composition, Glycemic Control, and Cardiorespiratory Fitness in Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

24669621

Hameed N

2012

Laparoscopic ovarian drilling for polycystic ovarian syndrome: treatment outcome.

24672165

Jain P

2013

Melatonin and its correlation with testosterone in polycystic ovarian syndrome.

24672951

Hong YL

2014

[Effect of Bushen Huatan Recipe on the Akt signal pathway in polycystic ovarian syndrome model rats with insulin resistance: an experimental research].

24674140

Banting LK

2014

Physical activity and mental health in women with polycystic ovary syndrome.

24676011

Soares Junior JM

2014

[Should insulin resistance be always treated in Polycystic Ovary Syndrome?].

24676694

Kahraman K

2014

Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.

24677210

Song LY

2014

Lack of association of INS VNTR polymorphism with polycystic ovary syndrome: a meta-analysis.

24680368

Mes-Krowinkel MG

2014

Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.

24680383

Becerra-Fern?ndez A

2014

Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.

24680396

Liu L

2014

A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatment.

24681545

Henry RK

2015

A macroprolactin level today may keep health care cost and the surgical knife at bay.

24684123

Zreik RS

2014

The prevalence of endocrinopathies among Lebanese women presenting with hirsutism to an endocrine clinic.

24685218

Brouillet S

2014

[Prokineticins: new regulatory peptides in human reproduction].

24685855

Sonthalia S

2014

Polycystic ovarian disease: still an enigma!

24685856

Madnani N

2014

Polycystic ovarian syndrome: a review.

24688118

Barry JA

2014

Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

24688934

Mohammadi E

2012

Benefits of omega-3 Fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome.

24688970

Saghafi-Asl M

2013

Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome.

24693338

Rezvanfar MA

2014

Ovarian aging-like phenotype in the hyperandrogenism-induced murine model of polycystic ovary.

24693495

Kwon SK

2014

Causes of amenorrhea in Korea: Experience of a single large center.

24694334

Niu Z

2014

Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.

24695544

Reverchon M

2014

Adipokines and the female reproductive tract.

24696694

Thathapudi S

2014

Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria.

24701474

Maleedhu P

2014

Status of Homocysteine in Polycystic Ovary Syndrome (PCOS).

24704923

Verit A

2014

Is there any effect of insulin resistance on male reproductive system?

24705280

Manco M

2014

Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index.

24705751

Niki H

2014

Improvement in diagnostic performance of the revised total testosterone measuring system in Japanese women with polycystic ovary syndrome.

24706793

McAllister JM

2014

Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.

24707685

Zhen Y

2014

Effect of HbA1C detection on the diagnostic screening for glucose metabolic disorders in polycystic ovary syndrome.

24708094

U?ar A

2014

Associations of size at birth and postnatal catch-up growth status with clinical and biomedical characteristics in prepubertal girls with precocious adrenarche: preliminary results.

24708600

Miri M

2014

Effect of exercise intensity on weight changes and sexual hormones (androstenedione and free testosterone) in female rats with estradiol valerate-induced PCOS.

24710644

Shah KN

2014

Phosphatidylinositide-3 kinase: a newer molecular target in metabolic and hormonal pathway of polycystic ovary syndrome.

24711896

Ouladsahebmadarek E

2014

Hormonal and metabolic effects of polyunsaturated fatty acid (omega-3) on polycystic ovary syndrome induced rats under diet.

24713888

Keefe CC

2014

Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.

24715509

Hoeger KM

2014

Developmental origins and future fate in PCOS.

24715510

Dumesic DA

2014

Intrauterine environment and polycystic ovary syndrome.

24715511

Barrett ES

2014

Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?

24715512

Welt CK

2014

Genetics of polycystic ovary syndrome.

24715513

Maliqueo M

2014

Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions.

24715514

Agapova SE

2014

Diagnosis and challenges of polycystic ovary syndrome in adolescence.

24715515

Anderson AD

2014

Childhood obesity and its impact on the development of adolescent PCOS.

24715516

Vitek W

2014

Treatment of polycystic ovary syndrome in adolescence.

24715517

Kudesia R

2014

Menopausal implications of polycystic ovarian syndrome.

24715518

Misso M

2014

Development of evidenced-based guidelines for PCOS and implications for community health.

24717046

Pohl A

2014

Uncovering steroidopathy in women with autism: a latent class analysis.

24717915

Lerchbaum E

2014

Vitamin D and female fertility.

24719635

Herskovitz I

2013

Female pattern hair loss.

24719724

Nasiri Amiri F

2014

Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran.

24719790

Mauvais-Jarvis F

2014

Developmental androgenization programs metabolic dysfunction in adult mice: Clinical implications.

24719967

Thornton P

2014

Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.

24720592

Nathan N

2014

The utility of metformin therapy in reproductive-aged women with polycystic ovary syndrome (PCOS).

24722128

Tantalaki E

2014

Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS).

24722366

Grynnerup AG

2014

Recent progress in the utility of anti-M?llerian hormone in female infertility.

24724557

Sahin SB

2014

Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome.

24728953

Cicero AF

2014

Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.

24730585

Aydin K

2014

Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.

24734869

Vrbikova J

2014

The utility of fasting plasma glucose to identify impaired glucose metabolism in women with polycystic ovary syndrome.

24734870

Chen H

2014

Live birth following vitrification of in vitro matured oocytes derived from sibling smaller follicles at follicle selection phase in the context of in vitro fertilization.

24735327

Keller E

2014

Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys.

24735887

McGee WK

2014

Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

24736483

Berberoglu Z

2014

Plasma GDF-15 levels and their association with hormonal and metabolic status in women with polycystic ovary syndrome aged 25-35.

24739314

Ketha H

2014

Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century.

24740546

Ott J

2014

Perioperative androstenedione kinetics in women undergoing laparoscopic ovarian drilling: a prospective study.

24741072

Smith P

2014

Development of mammalian ovary.

24741453

Kim E

2014

Correlation between Expression of Glucose Transporters in Granulosa Cells and Oocyte Quality in Women with Polycystic Ovary Syndrome.

24741513

Ahmed S

2014

Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women.

24741521

Ramanand SJ

2014

Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome.

24742124

Glintborg D

2014

Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.

24743397

Gambineri A

2014

Tissue-specific dysregulation of 11?-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.

24743683

Hsu CL

2014

Characteristics of harmonic indexes of the arterial blood pressure waveform in polycystic ovary syndrome.

24745161

Drosdzol-Cop A

2014

[Diagnosing polycystic ovary syndrome in adolescent girls].

24745164

Polish Gynecological Society.

2014

[Statement of the Polish Gynecological Society on the application of myo-inozytol in patients with PCOS (polycystic ovary syndrome)].

24746168

Chen B

2014

A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndrome.

24746743

Cui Y

2014

Age-specific serum antim?llerian hormone levels in women with and without polycystic ovary syndrome.

24747343

Roland AV

2014

Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.

24750325

Sravan Kumar P

2014

Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: a case-control study.

24751759

Zhuang J

2014

Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China.

24752393

Livadas S

2014

Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

24754183

Jin XT

2014

[Clinical efficacy observation on therapy ovulation failure infertility caursed by PCOS with reinforcing kidney, activating blood circulation and ovarian stimulation compound recipe].

24754853

Hirata T

2014

Concomitant ovarian drilling and oocyte retrieval by laparoendoscopic single-site surgery led to live birth using in vitro maturation of oocyte and transfer of frozen-thawed blastocyst in woman with polycystic ovary syndrome.

24758641

Vandekerckhove F

2014

Delaying the oocyte maturation trigger by one day leads to a higher metaphase II oocyte yield in IVF/ICSI: a randomised controlled trial.

24762064

Kabiri N

2014

Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation.

24765590

Whigham LD

2014

Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

24765893

Prakansamut N

2014

The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern.

24767186

Zouboulis CC

2014

Acne as a chronic systemic disease.

24767305

Braidy C

2014

[Comparison of fertiloscopy versus laparoscopy in the exploration of the infertility: analysis of the literature].

24768234

Huang R

2014

Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.

24768413

Ben-Shlomo I

2014

Basic research in PCOS: are we reaching new frontiers?

24768424

Tuten A

2014

Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions.

24770999

Homburg R

2014

The role of AMH in anovulation associated with PCOS: a hypothesis.